- Home
- BLRX vs OM Comparison
BLRX vs OM Comparison
Compare BLRX & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- OM
- Stock Information
- Founded
- BLRX 2003
- OM 2003
- Country
- BLRX Israel
- OM United States
- Employees
- BLRX N/A
- OM N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BLRX Health Care
- OM Health Care
- Exchange
- BLRX Nasdaq
- OM Nasdaq
- Market Cap
- BLRX 36.0M
- OM 31.8M
- IPO Year
- BLRX 2011
- OM 2020
- Fundamental
- Price
- BLRX $0.48
- OM $0.79
- Analyst Decision
- BLRX Strong Buy
- OM Buy
- Analyst Count
- BLRX 2
- OM 4
- Target Price
- BLRX $11.50
- OM $4.38
- AVG Volume (30 Days)
- BLRX 407.5K
- OM 1.0M
- Earning Date
- BLRX 11-29-2024
- OM 11-06-2024
- Dividend Yield
- BLRX N/A
- OM N/A
- EPS Growth
- BLRX N/A
- OM N/A
- EPS
- BLRX N/A
- OM N/A
- Revenue
- BLRX $17,048,000.00
- OM $114,729,000.00
- Revenue This Year
- BLRX N/A
- OM N/A
- Revenue Next Year
- BLRX N/A
- OM $11.81
- P/E Ratio
- BLRX N/A
- OM N/A
- Revenue Growth
- BLRX N/A
- OM N/A
- 52 Week Low
- BLRX $0.39
- OM $0.44
- 52 Week High
- BLRX $1.93
- OM $6.37
- Technical
- Relative Strength Index (RSI)
- BLRX 53.32
- OM 59.61
- Support Level
- BLRX $0.40
- OM $0.80
- Resistance Level
- BLRX $0.46
- OM $0.93
- Average True Range (ATR)
- BLRX 0.03
- OM 0.09
- MACD
- BLRX 0.01
- OM 0.03
- Stochastic Oscillator
- BLRX 94.50
- OM 65.84
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.